6.
Teichert J, Hermann R, Ruus P, Preiss R
. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol. 2003; 43(11):1257-67.
DOI: 10.1177/0091270003258654.
View
7.
Fogacci F, Rizzo M, Krogager C, Kennedy C, Georges C, Knezevic T
. Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies. Antioxidants (Basel). 2020; 9(10).
PMC: 7603186.
DOI: 10.3390/antiox9101011.
View
8.
Seifar F, Khalili M, Khaledyan H, Amiri Moghadam S, Izadi A, Azimi A
. α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review. Nutr Neurosci. 2017; 22(5):306-316.
DOI: 10.1080/1028415X.2017.1386755.
View
9.
Gomes M, Negrato C
. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetol Metab Syndr. 2014; 6(1):80.
PMC: 4124142.
DOI: 10.1186/1758-5996-6-80.
View
10.
Karalis D, Karalis T, Karalis S, Kleisiari A, Malakoudi F, Maimari K
. The Effect of Alpha-Lipoic Acid on Diabetic Peripheral Neuropathy and the Upcoming Depressive Disorders of Type II Diabetics. Cureus. 2021; 13(1):e12773.
PMC: 7888960.
DOI: 10.7759/cureus.12773.
View
11.
Teichert J, Tuemmers T, Achenbach H, Preiss C, Hermann R, Ruus P
. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J Clin Pharmacol. 2005; 45(3):313-28.
DOI: 10.1177/0091270004270792.
View
12.
Santos S, Romeiro C, Rodrigues C, Cerqueira A, Monteiro M
. Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease?. Oxid Med Cell Longev. 2019; 2019:8409329.
PMC: 6914903.
DOI: 10.1155/2019/8409329.
View
13.
Chiwele I, Jones B, Podczeck F
. The shell dissolution of various empty hard capsules. Chem Pharm Bull (Tokyo). 2000; 48(7):951-6.
DOI: 10.1248/cpb.48.951.
View
14.
Leane M, Pitt K, Reynolds G, Dawson N, Ziegler I, Szepes A
. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing. Pharm Dev Technol. 2018; 23(10):964-977.
DOI: 10.1080/10837450.2018.1534863.
View
15.
Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B
. Lipoic acid - biological activity and therapeutic potential. Pharmacol Rep. 2011; 63(4):849-58.
DOI: 10.1016/s1734-1140(11)70600-4.
View
16.
Viana M, Lauria P, de Lima A, Opretzka L, Marcelino H, Villarreal C
. Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain. Antioxidants (Basel). 2022; 11(12).
PMC: 9774895.
DOI: 10.3390/antiox11122420.
View
17.
Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K
. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 2007; 46(5):237-9.
DOI: 10.2169/internalmedicine.46.1893.
View
18.
Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst K, Kearney J, Knutsen H
. Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA J. 2021; 19(6):e06577.
PMC: 8173454.
DOI: 10.2903/j.efsa.2021.6577.
View
19.
Padmalayam I, Hasham S, Saxena U, Pillarisetti S
. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes. 2008; 58(3):600-8.
PMC: 2646058.
DOI: 10.2337/db08-0473.
View
20.
Brufani M, Figliola R
. (R)-α-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy. Acta Biomed. 2014; 85(2):108-15.
View